Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,675 | 72,287 | 53,506 | 17,974 | 2,109 |
| Receivables | N/A | N/A | N/A | N/A | 110 |
| TOTAL | $73,732 | $72,925 | $54,090 | $18,240 | $2,501 |
| Non-Current Assets | |||||
| PPE Net | 2,820 | 2,882 | 1,752 | 1,075 | 357 |
| Other Non-Current Assets | 130 | 130 | 130 | 130 | 53 |
| TOTAL | $2,950 | $3,012 | $1,882 | $1,205 | $410 |
| Total Assets | $76,682 | $75,937 | $55,972 | $19,445 | $2,911 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,549 | 1,264 | 1,912 | 1,010 | 159 |
| Accrued Expenses | 6,542 | 4,339 | 1,750 | 2,580 | 1,164 |
| TOTAL | $13,620 | $6,992 | $4,154 | $3,693 | $1,560 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 237 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $35 |
| Total Liabilities | $13,620 | $6,992 | $4,154 | $3,693 | $1,595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,531 | 23,724 | 15,281 | 10,002 | 2,003 |
| Common Shares | 292 | 237 | 152 | 2,002 | 401 |
| Retained earnings | -315,237 | -238,870 | -183,587 | -160,239 | -148,425 |
| TOTAL | $63,062 | $68,945 | $51,818 | $15,752 | $1,316 |
| Total Liabilities And Equity | $76,682 | $75,937 | $55,972 | $19,445 | $2,911 |